Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says ...

The S&P 500 won't pull back next year as the market enters the third year of a cyclical bull run, Brian Belski said.

Brian Belski, chief investment strategist at BMO Capital Markets, joins 'Halftime Report' to lay out his case for his firm's ...

TJX Cos raised its annual profit forecast on Wednesday, benefiting from lower costs and strong demand from cash-strapped ...

Salesforce (NYSE:CRM – Free Report) had its price target upped by BMO Capital Markets from $305.00 to $385.00 in a research ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 1.50% of ...

Goldman Sachs sees the S&P 500 gaining 11% over the next year as stock market gains continue to broaden out from a few large ...

Pfizer Inc. named oncology research head Chris Boshoff as the drug company’s chief scientific officer, replacing Mikael ...

Donald Trump’s presidential win is likely to be gold positive in the medium term, according to John Reade, chief market ...

American Rare Earths Limited (ASX: ARR \| OTCQX: ARRNF \| ADR: AMRRY) ("ARR" or "the Company") is excited to announce the engagement of BMO ...

Yields on U.S. government debt were broadly moving higher Wednesday morning as traders focused on the prospects for U.S. economic growth. The 10-year yield rose to roughly 4.43% in New York morning ...